ASIT Biotech S.A. announced that its AGM will be held on June 14, 2018 and consider proposal of the nomination and remuneration committee, to appoint Harry Welten as director for a term of 4 years, ending on the annual shareholders' meeting of 2022 that will approve the financial statements of the financial year ended December 31, 2021.